Liquid Biopsy

Detect cancer from a single blood draw

CircDNA.com is the premium domain for circulating DNA technology - the liquid biopsy revolution that's replacing invasive tissue biopsies with a simple blood test for cancer detection, monitoring, and treatment selection.

$8.2B
Market by 2028
50+
Cancer Types Detected
95%
Specificity Rates
.COM
Category Domain

Cancer sheds DNA into blood. We find it.

Circulating tumor DNA (ctDNA) carries the genetic fingerprint of cancer. Liquid biopsy captures this signal without surgery.

01

Non-Invasive

No surgery, no tissue biopsy. A simple blood draw provides a complete picture of tumor genetics and treatment response.

02

Early Detection

Multi-cancer early detection tests find signals years before symptoms appear. GRAIL, Guardant, Foundation Medicine are racing here.

03

Real-Time Monitoring

Track treatment response, detect minimal residual disease, catch recurrence early. Repeat testing without repeated biopsies.

04

Precision Medicine

Match patients to targeted therapies based on tumor mutations. Guide treatment selection without invasive procedures.

Own the category.

CircDNA.com is the exact-match domain for circulating DNA - the core technology behind liquid biopsy, cancer screening, and precision oncology.

Perfect for diagnostics companies, oncology platforms, research institutions, or biotech startups in the liquid biopsy space.